RECRUITING

PEER Trial: Part 2 Rice Technologies

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The study aims to compare the accuracy of the lateral flow test to detect HPV at the POC with commercially available HPV test and to determine the diagnostic accuracy and reliability of a multimodal optical imaging system to detect cervical dysplasia, with the gold reference standard of histopathology.

Official Title

Assessment of New Technologies for the Screening and Diagnosis of Cervical Cancer in Mozambique, A Study to be Conducted in Maputo Central Hospital, Mavalane and Jose Macamo General Hospitals and Mavalane Health Center

Quick Facts

Study Start:2021-03-24
Study Completion:2028-03-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05372484

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:25 Years to 49 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. 25 - 49 year old women
  2. 2. Women with a positive cervical cancer screening test (abnormal cytology, positive VIA and/or positive HPV test)
  3. 3. Women with intact cervix
  4. 4. Women who are not pregnant and with a negative pregnancy test (within 14 days from the date of enrollment) ) and not currently breastfeeding
  5. 5. Willing and capable of providing informed consent
  1. 1. Women under 25 or over 49 years old
  2. 2. Women who have undergone a total hysterectomy (with removal of the cervix)
  3. 3. Women who are pregnant or breastfeeding

Contacts and Locations

Study Contact

Mila Salcedo, PhD
CONTACT
(832) 696-6794
mpsalcedo@mdanderson.org

Principal Investigator

Kathleen Schmeler, MD
PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center

Study Locations (Sites)

M D Anderson Cancer Center
Houston, Texas, 77030
United States

Collaborators and Investigators

Sponsor: M.D. Anderson Cancer Center

  • Kathleen Schmeler, MD, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-03-24
Study Completion Date2028-03-30

Study Record Updates

Study Start Date2021-03-24
Study Completion Date2028-03-30

Terms related to this study

Keywords Provided by Researchers

  • Human Papilloma virus
  • Point-of-care HPV Test
  • Multimodal Optical Imaging
  • Screening

Additional Relevant MeSH Terms

  • Cervical Cancer